Centene Corporation
Centene Reports Q3 2024 Financial Results
Summary
Centene Corporation announced its financial results for the third quarter of 2024, reporting diluted EPS of $1.36 and adjusted diluted EPS of $1.62. Premium and service revenues were $36.9 billion, with notable membership increases in Marketplace and Medicare Prescription Drug Plans. The company also provided an update on its share repurchase program, having repurchased $1.2 billion of shares in Q3 and an additional $380 million in October. Centene reaffirmed its 2024 adjusted diluted EPS guidance of greater than $6.80.
Profitelligence Alerts
Get alerts for CNC
Be first to know when Centene Corporation files with the SEC.
Filing Categories
Exhibits (1)
Advertisement
About Centene Corporation
Centene Corporation is a diversified healthcare enterprise providing a comprehensive range of managed care services to government-sponsored healthcare programs. Specializing in serving uninsured and underinsured populations, Centene offers health plans, benefits management, and other related services. It operates through two primary segments: Managed Care and Specialty Services. The Managed Care segment provides health plan coverage to individuals through Medicaid, Medicare Advantage, and the Health Insurance Marketplace, impacting millions of lives across the United States. Meanwhile, the Specialty Services segment enhances healthcare quality and affordability through offerings such as pharmacy solutions, behavioral health, and optometry services. Founded in 1984 and headquartered in St. Louis, Missouri, Centene plays a significant role in the healthcare sector by addressing accessibility and cost challenges, thereby shaping market trends and influencing policy developments. As a major participant in the managed care industry, Centene is crucial for promoting coordinated care and improving health outcomes for vulnerable populations.
Official SEC Documents
Advertisement